Brief: Theralase Launches Seventh Us-Based Clinical Study Site And Treats First Patient In The Us
June 11 (Reuters) - Theralase Technologies Inc TLT.V :
* THERALASE® LAUNCHES SEVENTH US-BASED CLINICAL STUDY SITE
AND
TREATS FIRST PATIENT IN THE US
Source text for Eikon: ID:nGNXcbrfhl
Further company coverage: TLT.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theralase Technologies
See all newsBrief: Theralase Releases FY2022 Audited Financial Statements
Brief: Theralase Commences $CAN 2.5 M Follow-On Private Placement Equity Financing
Brief: Theralase Closes $2.5 Mln Private Placement Equity Financing
Brief: Theralase Phase IB NMIBC Clinical Study Published
Brief: Theralase® Demonstrates Proof-Of-Concept For Canadian-Made COVID-19 Vaccine